Cargando…
Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone
Background. This randomized, multicenter, open-label clinical trial was intended to generate pilot data on the efficacy and safety of the gonadotropin-releasing hormone agonist (GnRHa) deslorelin (D) with low-dose estradiol ± testosterone (E(2) ± T) add-back for endometriosis-related pelvic pain. M...
Autores principales: | Agarwal, Sanjay K., Daniels, AnnaMarie, Drosman, Steven R., Udoff, Laurence, Foster, Warren G., Pike, Malcolm C., Spicer, Darcy V., Daniels, John R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736002/ https://www.ncbi.nlm.nih.gov/pubmed/26881208 http://dx.doi.org/10.1155/2015/934164 |
Ejemplares similares
-
Fertility preservation and GnRHa for chemotherapy: debate
por: Blumenfeld, Zeev
Publicado: (2014) -
GnRHa trigger—the story of the ugly duckling
por: Humaidan, Peter, et al.
Publicado: (2023) -
Just as Tall on Testosterone; a Neutral to Positive Effect on Adult Height of GnRHa and Testosterone in Trans Boys
por: Willemsen, Lieve Anne, et al.
Publicado: (2022) -
The Luteal Phase after GnRHa Trigger-Understanding
An Enigma
por: Leth-Moller, Kathrine, et al.
Publicado: (2014) -
Treatment of central precocious puberty using low dose GnRH analogs (GnRHa)
por: Jahagirdar, Rahul, et al.
Publicado: (2015)